Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuele Grandi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Langenbeck'S Archives of Surgery|November 27, 2025
Complications following upfront pancreatectomy with venous resection do not compromise adjuvant chemotherapy delivery and survival in pancreatic cancerGiampaolo Perri, Samuele Grandi, Muyue Liu, et al.
Surgical Oncology|March 14, 2025
Prediction of early recurrence as a marker of surgical futility in pancreatic adenocarcinomaDavide Citterio, Michele Droz Dit Busset, Carlo Sposito, et al.
JAMA Network Open|March 28, 2023
Evaluation of Survival Following Surgical Resection for Small Nonfunctional Pancreatic Neuroendocrine TumorsToshitaka Sugawara, Salvador Rodriguez Franco, Michael J Kirsch, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 2, 2026
Incidence and consequences of chyle leak after pancreatectomy for pancreatic cancerJun Ishida, Oskar Franklin, Salvador R Franco, et al.
BMC Cancer|January 12, 2026
Conversion surgery vs. standard of care in pancreaTic cancer oligometastatic to the liver (SONAR: Surgery in Oligometastatic paNcreatic cAnceR) a randomized controlled trialRiccardo Guastella, Giampaolo Perri, Domenico Bassi, et al.
JAMA Oncology|December 8, 2022
Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant ChemotherapyToshitaka Sugawara, Salvador Rodriguez Franco, Samantha Sherman, et al.
Langenbeck'S Archives of Surgery|April 9, 2026
Prognostic impact of pathologically confirmed venous infiltration during upfront pancreatectomy: multicenter survival analysisGiampaolo Perri, Riccardo Guastella, Muyue Liu, et al.
Annals of Surgery|May 25, 2023
Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Pancreatic Adenocarcinoma: An Updated Nationwide StudyToshitaka Sugawara, Salvador Rodriguez Franco, Samantha Sherman, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 28, 2024
Characteristics and prognosis of patients with pancreatic adenocarcinoma not expressing CA19-9: Analysis of the National Cancer DatabaseToshitaka Sugawara, Salvador Rodriguez Franco, Samantha Sherman, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Langenbeck'S Archives of Surgery|November 27, 2025
Complications following upfront pancreatectomy with venous resection do not compromise adjuvant chemotherapy delivery and survival in pancreatic cancerGiampaolo Perri, Samuele Grandi, Muyue Liu, et al.
Surgical Oncology|March 14, 2025
Prediction of early recurrence as a marker of surgical futility in pancreatic adenocarcinomaDavide Citterio, Michele Droz Dit Busset, Carlo Sposito, et al.
JAMA Network Open|March 28, 2023
Evaluation of Survival Following Surgical Resection for Small Nonfunctional Pancreatic Neuroendocrine TumorsToshitaka Sugawara, Salvador Rodriguez Franco, Michael J Kirsch, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 2, 2026
Incidence and consequences of chyle leak after pancreatectomy for pancreatic cancerJun Ishida, Oskar Franklin, Salvador R Franco, et al.
BMC Cancer|January 12, 2026
Conversion surgery vs. standard of care in pancreaTic cancer oligometastatic to the liver (SONAR: Surgery in Oligometastatic paNcreatic cAnceR) a randomized controlled trialRiccardo Guastella, Giampaolo Perri, Domenico Bassi, et al.
JAMA Oncology|December 8, 2022
Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant ChemotherapyToshitaka Sugawara, Salvador Rodriguez Franco, Samantha Sherman, et al.
Langenbeck'S Archives of Surgery|April 9, 2026
Prognostic impact of pathologically confirmed venous infiltration during upfront pancreatectomy: multicenter survival analysisGiampaolo Perri, Riccardo Guastella, Muyue Liu, et al.
Annals of Surgery|May 25, 2023
Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Pancreatic Adenocarcinoma: An Updated Nationwide StudyToshitaka Sugawara, Salvador Rodriguez Franco, Samantha Sherman, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 28, 2024
Characteristics and prognosis of patients with pancreatic adenocarcinoma not expressing CA19-9: Analysis of the National Cancer DatabaseToshitaka Sugawara, Salvador Rodriguez Franco, Samantha Sherman, et al.
Pageof 2